drugset
drugset / Trial / NCT01764464

GRASSP: Gralise® for Spine Surgery Pain

NCT01764464 ↗

Phase 4 Completed 53 enrolled University of Rochester
RandomizedCrossoverTriple-blindTreatment

Summary

Evaluate the analgesic benefit of Gralise® for post-laminectomy pain syndrome (PLPS)

Timeline

Start
2012-12
Primary completion
2016-03
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1800 mg —

Indications

No indication recorded.